Tempest Therapeutics Shares Resume Trade
Portfolio Pulse from Benzinga Newsdesk
Trading of Tempest Therapeutics shares has resumed.
October 11, 2023 | 2:54 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Trading of Tempest Therapeutics shares has resumed, which may affect the stock's price.
The resumption of trading can lead to increased volatility in the stock's price. Investors may react positively or negatively to this news, depending on their perception of the company's prospects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100